WOODSTOCK BOWER GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: C87003 | ROTHERHAM, S61 1AH
Showing results 101-150 of 586
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Rivaroxaban | 602 | 16.6K | £11.1K | -1.6% vs avg |
| Dulaglutide | 583 | 2,340 | £42.9K | +408.7% ▲ |
| Hypromellose | 576 | 7,170 | £2.3K | +334.7% ▲ |
| Sumatriptan succinate | 571 | 4,907 | £1.5K | +61.2% ▲ |
| 548 | 274.7K | £2.3K | +501.0% ▲ | |
| Finasteride | 540 | 14.1K | £505 | -17.5% ▼ |
| Morphine sulfate | 525 | 102.6K | £2.8K | -19.9% ▼ |
| Esomeprazole | 517 | 16.3K | £1.4K | +27.8% ▲ |
| Venlafaxine | 511 | 16.4K | £3.0K | -39.5% ▼ |
| Clobetasone butyrate | 500 | 23.8K | £4.8K | +145.0% ▲ |
| Diltiazem hydrochloride | 495 | 19.7K | £3.4K | +61.2% ▲ |
| Nitrofurantoin | 488 | 6,658 | £3.9K | +2.3% ▲ |
| Bisacodyl | 482 | 21.4K | £1.2K | +267.7% ▲ |
| Lactulose | 481 | 289.1K | £2.7K | +46.1% ▲ |
| Formoterol/glycopyrronium/budesonide | 474 | 479 | £20.3K | +687.1% ▲ |
| Hyoscine butylbromide | 464 | 43.6K | £3.0K | +99.1% ▲ |
| Betahistine hydrochloride | 464 | 36.5K | £1.2K | +94.4% ▲ |
| Mometasone furoate | 460 | 467 | £3.6K | +14.6% ▲ |
| 455 | 976 | £32.0K | -16.5% ▼ | |
| Fluticasone propionate (Inhalation) | 451 | 490 | £10.1K | +16.6% ▲ |
| Lymecycline | 445 | 15.5K | £1.8K | +270.0% ▲ |
| Zopiclone | 443 | 7,858 | £336 | -20.0% ▼ |
| Risperidone | 439 | 20.2K | £1.1K | +73.5% ▲ |
| 438 | 438 | £19.4K | +41.0% ▲ | |
| Chlorphenamine maleate | 436 | 30.4K | £803 | +295.0% ▲ |
| Mirabegron | 410 | 11.8K | £10.9K | +2.1% ▲ |
| Estradiol | 409 | 19.9K | £4.0K | -50.2% ▼ |
| Quinine sulfate | 406 | 10.3K | £1.7K | +40.2% ▲ |
| Acetylcysteine | 401 | 11.5K | £7.4K | +460.9% ▲ |
| Sodium valproate | 401 | 101.9K | £5.8K | +26.1% ▲ |
| Calcipotriol | 401 | 38.9K | £22.3K | +135.6% ▲ |
| Trimethoprim | 397 | 9,888 | £780 | +94.3% ▲ |
| Hydroxocobalamin | 393 | 537 | £1.2K | -18.3% ▼ |
| Mesalazine (Systemic) | 389 | 33.1K | £15.1K | +62.4% ▲ |
| Bumetanide | 386 | 19.2K | £1.9K | +41.7% ▲ |
| Mometasone furoate | 386 | 17.6K | £1.8K | +188.7% ▲ |
| Quetiapine | 385 | 12.3K | £7.2K | -38.2% ▼ |
| Eplerenone | 384 | 10.5K | £1.3K | +44.8% ▲ |
| Desogestrel | 384 | 43.4K | £1.2K | -3.1% ▼ |
| Nebivolol | 381 | 11.1K | £4.0K | +259.4% ▲ |
| Methotrexate | 375 | 10.3K | £651 | +15.2% ▲ |
| Nitrazepam | 373 | 6,464 | £3.6K | +617.9% ▲ |
| Clotrimazole | 371 | 4,918 | £2.5K | +236.3% ▲ |
| Ketoconazole | 370 | 50.2K | £8.2K | +276.8% ▲ |
| Digoxin | 368 | 10.7K | £775 | -2.8% ▼ |
| Lacidipine | 363 | 10.3K | £852 | +203.8% ▲ |
| Fluticasone furoate/vilanterol | 348 | 348 | £8.1K | +124.8% ▲ |
| Estradiol with progestogen | 343 | 14.3K | £8.9K | +0.6% vs avg |
| Insulin aspart | 341 | 2,264 | £13.9K | -10.4% ▼ |
| Oxybutynin | 340 | 17.6K | £4.1K | +78.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.